Compared with Whites, Black, Indigenous, and people of color (BIPOC) communities in the US experience disproportionate health consequences from tobacco use, particularly commercial cigarettes. Cigarette smoking prevalence rates are higher among certain BIPOC communities. Among people who smoke, those who identify as BIPOC, compared to their White counterparts, experience a greater morbidity and mortality from tobacco-related chronic diseases, especially CVD & RCC. Although there are numerous evidence-based cessation treatments (EBCT) for tobacco cessation, during quit attempts, BIPOC are less likely than Whites to receive and utilize EBCT. Structural and interpersonal racism and discrimination including access to EBCTs may account for their lower utilization among BIPOC patients. Few EBCTs have been specifically developed, rigorously evaluated, or implemented for BIPOC patients.